[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 68, "title": "CEO, CFO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 48, "title": "President & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Skare Ph.D.", "title": "Vice President & Global Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Izanec M.D.", "title": "VP & Head of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.9, "open": 1.97, "dayLow": 1.86, "dayHigh": 2.03, "regularMarketPreviousClose": 1.9, "regularMarketOpen": 1.97, "regularMarketDayLow": 1.86, "regularMarketDayHigh": 2.03, "payoutRatio": 0.0, "beta": 1.616, "forwardPE": -8.652174, "volume": 5977079, "regularMarketVolume": 5977079, "averageVolume": 5020211, "averageVolume10days": 6324620, "averageDailyVolume10Day": 6324620, "bid": 1.26, "ask": 2.18, "bidSize": 2, "askSize": 2, "marketCap": 296914400, "fiftyTwoWeekLow": 0.53, "fiftyTwoWeekHigh": 2.64, "allTimeHigh": 5627700.0, "allTimeLow": 0.53, "fiftyDayAverage": 1.9994, "twoHundredDayAverage": 1.16315, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 291502400, "profitMargins": 0.0, "floatShares": 102195342, "sharesOutstanding": 149003210, "sharesShort": 12819308, "sharesShortPriorMonth": 7946168, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0859, "heldPercentInsiders": 0.00014999999, "heldPercentInstitutions": 0.40969002, "shortRatio": 2.62, "shortPercentOfFloat": 0.086, "impliedSharesOutstanding": 149203210, "bookValue": 0.352, "priceToBook": 5.653409, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -11226000, "trailingEps": -2.07, "forwardEps": -0.23, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": -25.45, "52WeekChange": 0.08743167, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 1.99, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.4, "targetMedianPrice": 8.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 5227000, "totalCashPerShare": 0.035, "ebitda": -11454000, "totalDebt": 211000, "quickRatio": 1.508, "currentRatio": 1.963, "debtToEquity": 6.569, "returnOnAssets": -0.87811995, "returnOnEquity": -2.28635, "freeCashflow": -6624500, "operatingCashflow": -10084000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.99, "postMarketChange": 0.0, "regularMarketChange": 0.09, "regularMarketDayRange": "1.86 - 2.03", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5020211, "corporateActions": [], "postMarketTime": 1768006697, "regularMarketTime": 1767992401, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "fiftyTwoWeekLowChange": 1.46, "fiftyTwoWeekLowChangePercent": 2.754717, "fiftyTwoWeekRange": "0.53 - 2.64", "fiftyTwoWeekHighChange": -0.6500001, "fiftyTwoWeekHighChangePercent": -0.24621215, "fiftyTwoWeekChangePercent": 8.743167, "dividendDate": 1563408000, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.07, "epsForward": -0.23, "epsCurrentYear": -0.534, "priceEpsCurrentYear": -3.7265918, "fiftyDayAverageChange": -0.00940001, "fiftyDayAverageChangePercent": -0.0047014155, "twoHundredDayAverageChange": 0.82685006, "twoHundredDayAverageChangePercent": 0.7108714, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2026-01-09", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 4.73684, "regularMarketPrice": 1.99, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]